Healthcare and Pharmaceuticals industry

Rheumatology Drugs Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Rheumatology Drugs Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Rheumatology Drugs Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Rheumatology Drugs Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Takeda Pharmaceutical
  • Sanofi
  • Genentech
  • Novartis
  • Janssen Biotech
  • Amgen
  • AbbVie
  • Pfizer
  • Bristol-Myers Squibb Company
  • Merck & Co.

By the Product Type, the market is primarily segmented into:

  • Disease Modifying Anti-rheumatic Drugs
  • Nonsteroidal Anti-inflammatory Drugs
  • Corticosteroids
  • Uric Acid Drugs
  • Others

By Applications, the market is segmented into:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Rheumatology Drugs Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Rheumatology Drugs Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Rheumatology Drugs Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Rheumatology Drugs Market

The Rheumatology Drugs Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Rheumatology Drugs Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Rheumatology Drugs Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Rheumatology Drugs
1.1 Rheumatology Drugs Market Overview
1.1.1 Rheumatology Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Rheumatology Drugs Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Rheumatology Drugs Market by Type
1.3.1 Global Rheumatology Drugs Revenue (Million US$) and Growth Comparison by Type (2014-2025)
1.3.2 Global Rheumatology Drugs Revenue Market Share by Type in 2018
1.3.3 Disease Modifying Anti-rheumatic Drugs
1.3.4 Nonsteroidal Anti-inflammatory Drugs
1.3.5 Corticosteroids
1.3.6 Uric Acid Drugs
1.3.7 Others
1.4 Rheumatology Drugs Market by End Users/Application
1.4.1 Hospital Pharmacy
1.4.2 Retail Pharmacy
1.4.3 Online Pharmacy

2 Global Rheumatology Drugs Competition Analysis by Players
2.1 Global Rheumatology Drugs Market Size (Million US$) by Players (2014-2019)
2.2 Competitive Status
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Mergers & Acquisitions, Expansion Plans

3 Company (Top Players) Profiles and Key Data
3.1 Takeda Pharmaceutical
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Sanofi
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Genentech
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Novartis
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Janssen Biotech
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Amgen
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 AbbVie
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Pfizer
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Bristol-Myers Squibb Company
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Merck & Co.
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Rheumatology Drugs Revenue (Value) (2014-2019)
3.10.5 Recent Developments

4 Global Rheumatology Drugs Market Size by Type and Application (2014-2019)
4.1 Global Rheumatology Drugs Market Size by Type (2014-2019)
4.2 Global Rheumatology Drugs Market Size by Application (2014-2019)
4.3 Potential Application of Rheumatology Drugs in Future
4.4 Top Consumer/End Users of Rheumatology Drugs

5 North America Rheumatology Drugs Development Status and Outlook
5.1 North America Rheumatology Drugs Market Size (2014-2019)
5.2 North America Rheumatology Drugs Market Size and Market Share by Players (2014-2019)
5.3 North America Rheumatology Drugs Market Size by Application (2014-2019)

6 Europe Rheumatology Drugs Development Status and Outlook
6.1 Europe Rheumatology Drugs Market Size (2014-2019)
6.2 Europe Rheumatology Drugs Market Size and Market Share by Players (2014-2019)
6.3 Europe Rheumatology Drugs Market Size by Application (2014-2019)

7 China Rheumatology Drugs Development Status and Outlook
7.1 China Rheumatology Drugs Market Size (2014-2019)
7.2 China Rheumatology Drugs Market Size and Market Share by Players (2014-2019)
7.3 China Rheumatology Drugs Market Size by Application (2014-2019)

8 Rest of Asia Pacific Rheumatology Drugs Development Status and Outlook
8.1 Rest of Asia Pacific Rheumatology Drugs Market Size (2014-2019)
8.2 Rest of Asia Pacific Rheumatology Drugs Market Size and Market Share by Players (2014-2019)
8.3 Rest of Asia Pacific Rheumatology Drugs Market Size by Application (2014-2019)

9 Central & South America Rheumatology Drugs Development Status and Outlook
9.1 Central & South America Rheumatology Drugs Market Size (2014-2019)
9.2 Central & South America Rheumatology Drugs Market Size and Market Share by Players (2014-2019)
9.3 Central & South America Rheumatology Drugs Market Size by Application (2014-2019)

10 Middle East & Africa Rheumatology Drugs Development Status and Outlook
10.1 Middle East & Africa Rheumatology Drugs Market Size (2014-2019)
10.2 Middle East & Africa Rheumatology Drugs Market Size and Market Share by Players (2014-2019)
10.3 Middle East & Africa Rheumatology Drugs Market Size by Application (2014-2019)

11 Market Forecast by Regions and Application (2019-2025)
11.1 Global Rheumatology Drugs Market Size by Regions (2019-2025)
11.1.1 North America Rheumatology Drugs Revenue and Growth Rate (2019-2025)
11.1.2 Europe Rheumatology Drugs Revenue and Growth Rate (2019-2025)
11.1.3 China Rheumatology Drugs Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Rheumatology Drugs Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Rheumatology Drugs Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Rheumatology Drugs Revenue and Growth Rate (2019-2025)
11.2 Global Rheumatology Drugs Market Size by Application (2019-2025)
11.3 The Market Drivers in Future

12 Rheumatology Drugs Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List

List of Table
List of Tables and Figures

Figure Global Rheumatology Drugs Market Size (Million USD) Status and Outlook (2014-2025)
Table Global Rheumatology Drugs Market Size (Million USD) and Growth Rate by Regions (2014-2025)
Figure Global Rheumatology Drugs Market Share by Regions (2014-2019)
Figure North America Rheumatology Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Europe Rheumatology Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure China Rheumatology Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Rest of Asia Pacific Rheumatology Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Central & South America Rheumatology Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Middle East & Africa Rheumatology Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Rheumatology Drugs Market Share by Type in 2018 & 2025
Figure Disease Modifying Anti-rheumatic Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Nonsteroidal Anti-inflammatory Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2014-2019)
Figure Uric Acid Drugs Market Size (Million USD) and Growth Rate (2014-2019)
Figure Others Market Size (Million USD) and Growth Rate (2014-2019)
Table Global Rheumatology Drugs Market Size (Million US$) Comparison by Application (2014-2025)
Figure Global Rheumatology Drugs Market Share by Application in 2018 & 2025
Figure Rheumatology Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacy (2014-2019)
Figure Rheumatology Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacy (2014-2019)
Figure Rheumatology Drugs Market Size (Million USD) and Growth Rate in Online Pharmacy (2014-2019)
Table Global Rheumatology Drugs Revenue (Million US$) by Players (2014-2019)
Table Global Rheumatology Drugs Revenue Market Share by Players (2014-2019)
Eigure Rheumatology Drugs Market Size Share by Players in 2018
Table Global Rheumatology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Global Top 5 Players Rheumatology Drugs Market Share in 2018
Figure Global Top 10 Players Rheumatology Drugs Market Share in 2018
Table Rheumatology Drugs Key Players Product/Service
Table Mergers & Acquisitions, Expansion Plans
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Description and Business Overview
Table Takeda Pharmaceutical Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Takeda Pharmaceutical (2014-2019)
Table Takeda Pharmaceutical Rheumatology Drugs Recent Developments
Table Sanofi Basic Information List
Table Sanofi Description and Business Overview
Table Sanofi Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Sanofi (2014-2019)
Table Sanofi Rheumatology Drugs Recent Developments
Table Genentech Basic Information List
Table Genentech Description and Business Overview
Table Genentech Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Genentech (2014-2019)
Table Genentech Rheumatology Drugs Recent Developments
Table Novartis Basic Information List
Table Novartis Description and Business Overview
Table Novartis Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Novartis (2014-2019)
Table Novartis Rheumatology Drugs Recent Developments
Table Janssen Biotech Basic Information List
Table Janssen Biotech Description and Business Overview
Table Janssen Biotech Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Janssen Biotech (2014-2019)
Table Janssen Biotech Rheumatology Drugs Recent Developments
Table Amgen Basic Information List
Table Amgen Description and Business Overview
Table Amgen Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Amgen (2014-2019)
Table Amgen Rheumatology Drugs Recent Developments
Table AbbVie Basic Information List
Table AbbVie Description and Business Overview
Table AbbVie Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of AbbVie (2014-2019)
Table AbbVie Rheumatology Drugs Recent Developments
Table Pfizer Basic Information List
Table Pfizer Description and Business Overview
Table Pfizer Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Pfizer (2014-2019)
Table Pfizer Rheumatology Drugs Recent Developments
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Description and Business Overview
Table Bristol-Myers Squibb Company Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Bristol-Myers Squibb Company (2014-2019)
Table Bristol-Myers Squibb Company Rheumatology Drugs Recent Developments
Table Merck & Co. Basic Information List
Table Merck & Co. Description and Business Overview
Table Merck & Co. Rheumatology Drugs Products, Services and Solutions
Table Revenue (Million US$) in Rheumatology Drugs Business of Merck & Co. (2014-2019)
Table Merck & Co. Rheumatology Drugs Recent Developments
Table Global Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Figure Global Rheumatology Drugs Revenue Market Share by Type in 2018
Table Global Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Figure Global Rheumatology Drugs Revenue Market by Application in 2018
Table Top Consumer/End Users of Rheumatology Drugs
Figure North America Rheumatology Drugs Market Size and Growth Rate(2014-2019) (Million USD)
Table North America Rheumatology Drugs Market Size by Players (2014-2019)(Million US$)
Figure North America Rheumatology Drugs Market Size Share by Players in 2018
Table North America Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Figure North America Rheumatology Drugs Revenue Market Share by Application (2014-2019)
Figure North America Rheumatology Drugs Market Size Share by Application in 2018
Figure Europe Rheumatology Drugs Market Size and Growth Rate(2014-2019) (Million USD)
Table Europe Rheumatology Drugs Market Size by Players (2014-2019)(Million US$)
Figure Europe Rheumatology Drugs Market Size Share by Players in 2018
Table Europe Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Figure Europe Rheumatology Drugs Revenue Market Share by Application (2014-2019)
Figure Europe Rheumatology Drugs Market Size Share by Application in 2018
Figure China Rheumatology Drugs Market Size and Growth Rate(2014-2019) (Million USD)
Table China Rheumatology Drugs Market Size by Players (2014-2019)(Million US$)
Figure China Rheumatology Drugs Market Size Share by Players in 2018
Table China Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Figure China Rheumatology Drugs Revenue Market Share by Application (2014-2019)
Figure China Rheumatology Drugs Market Size Share by Application in 2018
Figure Rest of Asia Pacific Rheumatology Drugs Market Size and Growth Rate(2014-2019) (Million USD)
Table Rest of Asia Pacific Rheumatology Drugs Market Size by Players (2014-2019)(Million US$)
Figure Rest of Asia Pacific Rheumatology Drugs Market Size Share by Players in 2018
Table Rest of Asia Pacific Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Figure Rest of Asia Pacific Rheumatology Drugs Revenue Market Share by Application (2014-2019)
Figure Rest of Asia Pacific Rheumatology Drugs Market Size Share by Application in 2018
Figure Central & South America Rheumatology Drugs Market Size and Growth Rate(2014-2019) (Million USD)
Table Central & South America Rheumatology Drugs Market Size by Players (2014-2019)(Million US$)
Figure Central & South America Rheumatology Drugs Market Size Share by Players in 2018
Table Central & South America Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Figure Central & South America Rheumatology Drugs Revenue Market Share by Application (2014-2019)
Figure Central & South America Rheumatology Drugs Market Size Share by Application in 2018
Figure Middle East & Africa Rheumatology Drugs Market Size and Growth Rate(2014-2019) (Million USD)
Table Middle East & Africa Rheumatology Drugs Market Size by Players (2014-2019)(Million US$)
Figure Middle East & Africa Rheumatology Drugs Market Size Share by Players in 2018
Table Middle East & Africa Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Figure Middle East & Africa Rheumatology Drugs Revenue Market Share by Application (2014-2019)
Figure Middle East & Africa Rheumatology Drugs Market Size Share by Application in 2018
Figure Global Rheumatology Drugs Market Size and Growth Rate (Value) (2019-2025) (Million US$)
Table Global Rheumatology Drugs Market Size by Regions (2019-2025) (Million US$)
Figure Global Rheumatology Drugs Market Size Share by Regions (2019-2025)
Figure Global Rheumatology Drugs Market Size Share by Regions in 2025
Figure North America Rheumatology Drugs Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Rheumatology Drugs Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Rheumatology Drugs Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Rheumatology Drugs Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Rheumatology Drugs Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Rheumatology Drugs Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Rheumatology Drugs Market Size by Application (2019-2025) (Million USD)
Figure Global Rheumatology Drugs Market Size by Application (2019-2025)
Figure Global Rheumatology Drugs Market Size by Application in 2025
Table Global Rheumatology Drugs Market Size by Type (2019-2025) (Million US$)
Figure Global Rheumatology Drugs Market Size by Type (2019-2025)
Figure Global Rheumatology Drugs Market Size by Type in 2025
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 



Contact Us

U.S.A :  +1-415-871-0703

JAPAN :  +81-50-5539-1737


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Testimonials

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.